Non small cell lung cancer Dermatologic adverse events Lung cancer EGFR TKI Skin toxicity Self efficacy Self management Quality of life Randomized controlled trial
Conditions
Interventions
Participants receive a structured educational and supportive care program according to study protocol.
Duration: 16 weeks. Mode of delivery: Face to face sessions and telephone or online support.
Cont
Self efficacy based intervention,Usual care
Sponsors
Udon Thani Rajabhat University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age 18 years or older 2. Confirmed diagnosis of EGFR mutation positive advanced non small cell lung cancer Receiving EGFR tyrosine kinase inhibitor therapy for at least 4 weeks 3. Presence of dermatologic adverse events related to treatment 4. Ability to communicate and provide informed consent
Exclusion criteria
Exclusion criteria: 1. Unawareness of cancer diagnosis 2. Severe physical or functional impairment 3. Dermatologic conditions not related to EGFR TKI therapy 4. Inability to complete questionnaires 5. Participation in other interventional studies related to skin adverse events
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin toxicity severity Baseline Week 8 Week 16 CTCAE version 5.0 | — |
Secondary
| Measure | Time frame |
|---|---|
| Self efficacy Baseline Week 8 Week 16 SUPPH scale,Self management Baseline Week 8 Week 16 SC CII version 2.0,Quality of life Baseline Week 8 Week 16 DLQI | — |
Countries
Thailand
Contacts
Public ContactMonthida Sangruangake
Faculty of Nursing, Udon Thani Rajabhat Universityng, Mueang Udon Thani
Outcome results
None listed